Y Gruel

1.3k total citations · 1 hit paper
25 papers, 950 citations indexed

About

Y Gruel is a scholar working on Surgery, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Y Gruel has authored 25 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Internal Medicine and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Y Gruel's work include Venous Thromboembolism Diagnosis and Management (12 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers) and Platelet Disorders and Treatments (5 papers). Y Gruel is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers) and Platelet Disorders and Treatments (5 papers). Y Gruel collaborates with scholars based in France, Switzerland and Canada. Y Gruel's co-authors include Paul Cottu, Zora Marjanovic, Jean Marc Extra, Dominique Farge, Christine Le Maignan, Guy Meyer, B. Lorcerie, Philippe Solal‐Céligny, B. Delahousse and C Guérois and has published in prestigious journals such as Blood, Anesthesiology and Thrombosis and Haemostasis.

In The Last Decade

Y Gruel

23 papers receiving 909 citations

Hit Papers

Comparison of Low-Molecular-Weight Heparin and Warfarin f... 2002 2026 2010 2018 2002 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Gruel France 10 796 560 361 267 183 25 950
John A. Norton United States 7 505 0.6× 397 0.7× 366 1.0× 201 0.8× 136 0.7× 15 827
Colin Chesterman Australia 4 735 0.9× 567 1.0× 353 1.0× 136 0.5× 204 1.1× 4 940
Sergio Siragusa Italy 14 614 0.8× 430 0.8× 291 0.8× 93 0.3× 271 1.5× 28 829
Stefano Cuppini Italy 11 721 0.9× 459 0.8× 281 0.8× 198 0.7× 266 1.5× 23 910
Tim Brighton Australia 13 451 0.6× 367 0.7× 184 0.5× 108 0.4× 366 2.0× 22 866
J. T. G. Renney Australia 7 725 0.9× 420 0.8× 384 1.1× 147 0.6× 165 0.9× 10 962
Francesco Sonaglia Italy 7 547 0.7× 322 0.6× 205 0.6× 196 0.7× 95 0.5× 14 623
Pascal d’Azemar France 9 1.3k 1.6× 972 1.7× 578 1.6× 259 1.0× 237 1.3× 13 1.5k
Andrew F. Mah Canada 8 891 1.1× 639 1.1× 319 0.9× 302 1.1× 127 0.7× 12 961
A.G.M. van den Belt Netherlands 4 805 1.0× 609 1.1× 348 1.0× 139 0.5× 223 1.2× 4 910

Countries citing papers authored by Y Gruel

Since Specialization
Citations

This map shows the geographic impact of Y Gruel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Gruel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Gruel more than expected).

Fields of papers citing papers by Y Gruel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Gruel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Gruel. The network helps show where Y Gruel may publish in the future.

Co-authorship network of co-authors of Y Gruel

This figure shows the co-authorship network connecting the top 25 collaborators of Y Gruel. A scholar is included among the top collaborators of Y Gruel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Gruel. Y Gruel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godiér, Anne, Dominique Lasne, Pierre Fontana, et al.. (2019). Iconographies supplémentaires de l'article : Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR). 1 indexed citations
2.
Siè, Piérre, Jean‐François Schved, & Y Gruel. (2017). Management of invasive procedures in patients with platelet disorders or thrombocytopenia Guidelines by French expert group on inherited platelet diseases. Sang thrombose vaisseaux. 29(4). 149–156.
3.
Albaladejo, Pierre, Piérre Siè, Vincent Mémier, et al.. (2017). Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants. Anesthesiology. 127(1). 111–120. 40 indexed citations
4.
Boubli, Léon, P. Coloby, P. Debourdeau, et al.. (2013). Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer – A real-world, prospective, observational French study: PRéOBS. Thrombosis Research. 133(6). 985–992. 15 indexed citations
5.
Meyer, Guy, Zora Marjanovic, B. Lorcerie, et al.. (2002). Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer. Archives of Internal Medicine. 162(15). 1729–1729. 620 indexed citations breakdown →
6.
Lemaire, Valérie, B Charbonnier, Y Gruel, Philippe Goupille, & Jean‐Pierre Valat. (2002). Antiagrégants, anticoagulants et infiltrations : comment faire ?. Revue du Rhumatisme. 69(1). 8–11.
7.
Lemaire, Valérie, B Charbonnier, Y Gruel, Philippe Goupille, & J.-P. Valat. (2002). Joint injections in patients on antiplatelet or anticoagulant therapy: risk minimization. Joint Bone Spine. 69(1). 8–11. 9 indexed citations
8.
Guilmot, J.‐L., Élisabeth Diot, & Y Gruel. (2000). [Contribution of platelet aggregation inhibitors in the prevention of complications of atherothrombosis].. PubMed. 29(13). 709–16. 3 indexed citations
9.
Gruel, Y. (1997). Thrombopénies induites par l'héparine : De la physiopathologie à la thérapeutique. 148(2). 136–141. 1 indexed citations
10.
Gruel, Y, G Pacouret, Sylvia Bellucci, & Jacques Caen. (1997). Severe Proximal Deep Vein Thrombosis in a Glanzmann Thrombasthenia Variant Successfully Treated With a Low Molecular Weight Heparin. Blood. 90(2). 888–889. 17 indexed citations
11.
Oliver, José M., Y Gruel, & Yannick Bacq. (1991). [Anomalies of hemostasis in hepatopathies].. PubMed. 15(10). 679–88. 3 indexed citations
12.
Babatasi, Gérard, et al.. (1990). [Gastropericardial fistula. Review of the literature apropos of an original case].. PubMed. 127(1). 6–12. 22 indexed citations
13.
14.
Wautier, Jean‐Luc, et al.. (1987). ANTENATAL DIAGNOSIS OF THROMBOPATHY. Thrombosis and Haemostasis. 2 indexed citations
15.
Gruel, Y & L. Drouet. (1986). [Thrombocytopenia induced by heparin. Diagnosis, treatment, physiopathology: current concepts].. PubMed. 137(6). 497–502. 2 indexed citations
16.
Gruel, Y, et al.. (1985). [Peroperative peritoneal lavage in peritonitis of appendicular origin in children. Apropos of 50 cases].. PubMed. 39(5). 305–8. 2 indexed citations
17.
Gruel, Y, et al.. (1985). [Thrombopenia and thrombosis under heparin treatment. Need for aggregation tests before treatment with low molecular weight heparin].. PubMed. 14(3). 166–166. 5 indexed citations
18.
Gruel, Y, et al.. (1985). A new method of ventilation with a mixture of helium and oxygen in the management of congenital diaphragmatic hernia. A preliminary study.. PubMed. 36(3). 119–26. 2 indexed citations
19.
Leclerc, Maxime, et al.. (1985). Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216). Seminars in Thrombosis and Hemostasis. 11(3). 326–329. 103 indexed citations
20.
Gruel, Y, et al.. (1983). [Value of neuroleptoanalgesia in preventing recurrence of fetal shunts during treatment of diaphragmatic hernias].. PubMed. 24(2). 140–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026